Apoprotein E phenotype determines serum cholesterol in infants during both high-cholesterol breast feeding and low-cholesterol formula feeding.

Our objective was to establish the role of the apoprotein (apo) E phenotype in determining serum cholesterol levels in infants fed exclusively on high-fat, high-cholesterol human milk and in those fed a low-cholesterol, high-unsaturated fat formula. The total and lipoprotein cholesterol, apoB, and triglyceride concentrations in serum were quantified and related to the apoE phenotype in 151 infants at birth and at 2, 6, 9, and 12 months of age. Forty-four had the E3/4 or 4/4 phenotype (E4 group), 94 had the E3/3 phenotype (E3 group), and 13 had the E2/3 or 2/4 phenotype (E2 group). In cord blood, cholesterol concentrations tended to be higher in the E4 than in the E2 group. With exclusive breast-feeding, the concentrations rose significantly faster and higher in the E4 group than in the E3 group or, especially, the E2 group. The values (mmol/L, mean +/- SEM) were 1.6 +/- 0.15, 1.5 +/- 0.05, 1.4 +/- 0.1 (P = n.s.) at birth; 4.2 +/- 0.1, 3.8 +/- 0.08, 3.4 +/- 0.2 (P < 0.001) at 2 months; 4.4 +/- 0.15, 3.9 +/- 0.1, 3.4 +/- 0.15 (P < 0.001) at 4 months; 4.3 +/- 0.17, 4.0 +/- 0.13, 3.7 +/- 0.26 (P < 0.001) at 6 months; 4.8 +/- 0.28, 4.4 +/- 0.11, 3.8 +/- 0.05 (P < 0.001) at 9 months; and 4.7 +/- 0.11, 4.4 +/- 0.08, 4.1 +/- 0.19 (P < 0.001) at 12 months, for the E4, E3, and E2 groups, respectively. Increases in LDL cholesterol and LDL apoB behaved similarly. The total triglyceride, and total HDL, HDL2, and HDL3 cholesterol concentrations did not depend on the apoE phenotype. Among infants fed high-fat, high-cholesterol human milk, the total and LDL-cholesterol concentrations and the LDL apoB concentration of those with the apoE phenotype 4/4 or 3/4 rose faster and to higher levels than in other infants. Among formula-fed infants, receiving a low-cholesterol, high-unsaturated fat diet, the differences between the apoE groups were smaller.

[1]  J. Breslow,et al.  Genetic basis of lipoprotein disorders. , 1995, The Journal of clinical investigation.

[2]  M. Siimes,et al.  Tracking of serum cholesterol and lipoprotein levels from the first year of life. , 1993, Pediatrics.

[3]  S. Srinivasan,et al.  Apolipoprotein E polymorphism and its association with serum lipoprotein concentrations in black versus white children: the Bogalusa Heart Study. , 1993, Metabolism: clinical and experimental.

[4]  H. Gylling,et al.  Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. , 1992, Journal of lipid research.

[5]  H. Gylling,et al.  Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  M. Siimes,et al.  Exclusive breast-feeding and weaning: effect on serum cholesterol and lipoprotein concentrations in infants during the first year of life. , 1992, Pediatrics.

[7]  T. Miettinen,et al.  Impact of apo E phenotype on the regulation of cholesterol metabolism. , 1991, Annals of medicine.

[8]  D. Schoeller,et al.  Association between apolipoprotein E phenotype and endogenous cholesterol synthesis as measured by deuterium uptake. , 1991, Cardiovascular research.

[9]  M. Savolainen,et al.  Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype. , 1991, Atherosclerosis.

[10]  P. Clifton,et al.  Relationship between sensitivity to dietary fat and dietary cholesterol. , 1990, Arteriosclerosis.

[11]  J. Huttunen,et al.  Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. , 1990, Arteriosclerosis.

[12]  T. Lehtimäki,et al.  Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. , 1990, Journal of lipid research.

[13]  M. Siimes,et al.  Cholesterol and its precursors in human milk during prolonged exclusive breast-feeding. , 1989, The American journal of clinical nutrition.

[14]  U. Beisiegel,et al.  The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein , 1989, Nature.

[15]  M. Nieminen,et al.  Apoprotein E Polymorphism and Coronary Artery Disease: Increased Prevalence of Apolipoprotein E‐4 in Angiographically Verified Coronary Patients , 1989, Arteriosclerosis.

[16]  H. Gylling,et al.  SERUM CHOLESTEROL RESPONSE TO DIETARY CHOLESTEROL AND APOPROTEIN E PHENOTYPE , 1988, The Lancet.

[17]  S. Grundy,et al.  Comparison of monounsaturated fatty acids and carbohydrates for reducing raised levels of plasma cholesterol in man. , 1988, The American journal of clinical nutrition.

[18]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[19]  M. Weintraub,et al.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. , 1987, The Journal of clinical investigation.

[20]  C. Ehnholm,et al.  Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. , 1987, The Journal of clinical investigation.

[21]  S. Grundy Monounsaturated fatty acids, plasma cholesterol, and coronary heart disease. , 1987, The American journal of clinical nutrition.

[22]  P. Demacker,et al.  Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype. , 1987, Journal of lipid research.

[23]  P. de Knijff,et al.  A rapid micromethod for apolipoprotein E phenotyping directly in serum. , 1987, Journal of lipid research.

[24]  G. Utermann,et al.  Apolipoprotein E polymorphism in health and disease. , 1987, American heart journal.

[25]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[26]  W. Mcconathy,et al.  Changes in the Serum Lipids and Apolipoproteins in the First Four Weeks of Life , 1986, Pediatric Research.

[27]  C. Ehnholm,et al.  Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. , 1986, Journal of lipid research.

[28]  C. Sing,et al.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. , 1985, American journal of human genetics.

[29]  G. Assmann,et al.  Apolipoprotein E Polymorphism and Coronary Artery Disease , 1983, Arteriosclerosis.

[30]  G. Miller,et al.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. , 1982, Journal of lipid research.

[31]  R. Mahley,et al.  Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. , 1982, The Journal of biological chemistry.

[32]  R. Mahley,et al.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. , 1981, The Journal of biological chemistry.

[33]  G. Utermann,et al.  Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man , 1977, Nature.

[34]  A. Raftery,et al.  A Stable Reagent for the Liebermann-Burchard Reaction. Application to Rapid Serum Cholesterol Determination , 1961 .

[35]  M. Katan,et al.  Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype. , 1991 .

[36]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[37]  E. Boerwinkle,et al.  Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. , 1988, American journal of human genetics.

[38]  J. Breslow,et al.  Human apolipoprotein E isoprotein subclasses are genetically determined. , 1981, American journal of human genetics.

[39]  S. Goldberg,et al.  Concurrent and subsequent serum cholesterol of breast- and formula-fed infants. , 1975, The American journal of clinical nutrition.

[40]  P. Röschlau,et al.  Enzymatische Bestimmung des Gesamt-Cholesterins im Serum , 1974 .